bioRxivImmunologyPreprint
Class-specific sensing of HIV-1 antigens by the B cell antigen receptor depends on the CH1 domain
Y. Ortiz, K. Anasti, A. K. Pane, K. Cronin, S. M. Alam, M. Reth
Abstract
How different classes of the B cell antigen receptor (BCR) sense viral antigens used in vaccination protocols is poorly understood. Here we study antigen binding and sensing of Ramos B cells expressing BCRs of either the IgM or IgG1 class with a specificity for the CD4-binding-site of the envelope (Env) protein of the human immune deficiency virus-1 (HIV-1). We find that, in spite of their identical antigen binding site, the two BCR classes differ drastically from each other in that the IgM-BCR and IgG1-BCR bind preferentially to monovalent and polyvalent antigens, respectively. By generating an IgM/IgG1 chimeric BCR we found that the class-specific antigen-sensing behavior can be transferred with the CH1{gamma} domain from the IgG1-BCR to the IgM-BCR. Our results indicate that the class-switching process not only results in the production of antibody classes with different effector functions but also alters the antigen sensing of secondary B lymphocytes. These findings suggest that antigen valency in existing vaccination protocols should be modified and altered between primary versus secondary (booster) immunization.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anti-HIV-1 B cell antigen receptor signaling and structure
Bhishem Thakur, Jahangir Alam, … S. Munir Alam·iSciencePeer-reviewed·Nov 1, 2026
- Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
M. D. Gray, J. Feng, … L. Stamatatos·bioRxiv·Aug 21, 2021
- Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-class antibodies
Parul Agrawal, Arineh Khechaduri, … Leonidas Stamatatos·bioRxiv·Mar 13, 2025
- Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans
Tom G. Caniels, Madhu S. Prabhakaran, … Rogier W. Sanders·bioRxiv·Oct 26, 2026
- B cells discriminate HIV-1 Envelope protein affinities by sensing antigen binding association rates
M. A. Hossain, K. Anasti, … S. M. Alam·bioRxiv·Jan 14, 2022
- Maturation of HIV-1 neutralizing antibodies in a germinal center conditional expression mouse model
Ming Tian, Jillian Davis, … Frederick W. Alt·PLoS PathogensPeer-reviewed·Jun 22, 2026